186
Views
5
CrossRef citations to date
0
Altmetric
Articles

CDKN2A Depletion Causes Aneuploidy and Enhances Cell Proliferation in Non-Immortalized Normal Human Cells

, , , &
Pages 338-348 | Received 06 Jan 2017, Accepted 17 May 2018, Published online: 23 Aug 2018
 

Abstract

Aneuploidy is a common feature of cancer cells and may contribute to cellular transformation and cancer development. In this study, we found that significant down-regulation of CDKN2A, CHEK2, CDCA8, TP53BP1, and CCNDBP1 led to chromosome imbalances in two diploid non-immortalized human cell lines; however, only CDKN2A inhibition enhanced cell proliferation and additionally up-regulated three cell cycle control genes: CDCA8, AURKA, and CCND. These results confirm that CDKN2A is a tumor suppressor gene driving human cancer development by inducing cell aneuploidy and cell cycle up-regulation.

Acknowledgments

Z. Hélias-Rodzewicz received a fellowship from the Institut National du Cancer (TAKIMAGI). We are grateful to Dr. Ch. Dani for the hMADS3 cell line and to technicians from the pathology and hematology departments of Ambroise Paré Hospital for their technical support.

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,193.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.